ClinicalTrials.Veeva

Menu

RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis

University of Maryland Baltimore (UMB) logo

University of Maryland Baltimore (UMB)

Status

Enrolling

Conditions

Subglottic Stenosis
Tracheal Stenosis

Treatments

Procedure: Biopsy or surgery

Study type

Observational

Funder types

Other

Identifiers

NCT07258784
HP-00114191

Details and patient eligibility

About

Benign tracheal stenosis is a rare but potentially life-threatening condition, typically resulting from fibroinflammatory scarring. It can be secondary to iatrogenic etiologies such as intubation or tracheostomy , as well as autoimmune diseases and being idiopathic. Patients typically undergoes endoscopic or surgical interventions to open up the airways. This project will analyze resected or biopsied tissue from patients with benign tracheal stenosis to define disease-specific RNA expression profiles.

Enrollment

10 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with benign tracheal stenosis

Exclusion criteria

  • Malignancy. active infection

Trial design

10 participants in 1 patient group

patients with benign tracheal stenosis undergoing either endoscopic or surgical treatment
Treatment:
Procedure: Biopsy or surgery

Trial contacts and locations

1

Loading...

Central trial contact

Chenchen Zhang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems